Physician profile
Mandeep Powar
NPI 1386646081
$1,142.14
in general payments reported to CMS, 2019-2025
12 companies · $83.92 in 2025
The $83.92 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2020: $95.21 · 2021: $103 · 2022: $173 · 2023: $193 · 2024: $349 · 2025: $83.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $485 · Travel and Lodging: $141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $484.83 |
| Travel and Lodging | $140.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $235.57 | 2023-2024 | Sprint Pns System |
| Abbvie INC. | $189.18 | 2023-2025 | |
| Nevro Corp. | $130.96 | 2020-2022 | |
| Grt US Holding, INC. | $129.78 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $99.27 | 2019 | |
| Curonix LLC | $97.95 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Averitas Pharma INC. | $81.84 | 2023-2025 | Qutenza |
| Pfizer INC. | $69.76 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $59.05 | 2021 | |
| Allergan, INC. | $23.00 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $21.01 | 2025 | |
| Forte Bio-Pharma LLC | $4.77 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mandeep Powar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.